CASP6 and colorectal carcinoma: In addition, a low CASP6 expression and high NLRP1 expression showed higher dysfunction and a lower exclusion score based on the TIDE algorithm, which implied that CASP6 and NLRP1 might be a potential prognostic marker and a therapeutic target for the immune microenvironment in CRC.